Advertisement
Advertisement

More Related Content

Advertisement

my note.pptx

  1. Drugs of Choice, First Choice, Alternative(s) 1. GRAM-POSITIVE COCCI 1 3/22/2023
  2. Enterococcus faecalis (generally not as resistant to antibiotics as Enterococcus faecium): • Serious infection (endocarditis, meningitis, pyelonephritis with bacteremia) – Ampicillin (or penicillin G) + (gentamicin or streptomycin) – Vancomycin + (gentamicin or streptomycin), daptomycin, linezolid, – tedizolid, telavancin, tigecyclinea • Urinary tract infection – Ampicillin, amoxicillin – Fosfomycin or nitrofurantoin 3/22/2023 2
  3. E. faecium (generally more resistant to antibiotics than E. faecalis): • Recommend consultation with infectious disease specialist – Linezolid, – quinupristin/dalfopristin, – daptomycin, – tigecycline 3/22/2023 3
  4. Staphylococcus aureus/Staphylococcus epidermidis: • Methicillin (oxacillin)-sensitive – Nafcillin or oxacillin – FGC,b,c trimethoprim–sulfamethoxazole, clindamycin, BL/BLId • Hospital-acquired methicillin (oxacillin)–resistant – Vancomycin ± (gentamicin or rifampin) – Ceftaroline, daptomycin, linezolid, telavancin, tigecycline, atrimethoprim– sulfamethoxazole, quinupristin–dalfopristin • Community-acquired methicillin (oxacillin)–resistant – Clindamycin, trimethoprim–sulfamethoxazole, doxycyclinea – Ceftaroline, dalbavancin, daptomycin, linezolid, oritivancin, tedizolid, telavancin, tigecycline,a or vancomycin 3/22/2023 4
  5. Streptococcus (groups A, B, C, G, and Streptococcus bovis): • Penicillin G or V or ampicillin • FGC,b,c erythromycin, azithromycin, clarithromycin 3/22/2023 5
  6. Streptococcus pneumonia: • Penicillin-sensitive (minimal inhibitory concentration [MIC] <0.1 mcg/mL [mg/L]) – Penicillin G or V or ampicillin – FGC,b,c doxycycline,a azithromycin, clarithromycin, erythromycin • Penicillin intermediate (MIC 0.1-1 mcg/mL [mg/L]) – High-dose penicillin (12 million units/day for adults) or ceftriaxonec or cefotaximec – Levofloxacin,a moxifloxacin,a gemifloxacin,a or vancomycin • Penicillin-resistant (MIC ≥1.0 mcg/mL [mg/L]) – Recommend consultation with infectious disease specialist. • Vancomycin ± rifampin • Per sensitivities: ceftaroline, cefotaxime, ceftriaxone,c levofloxacin,a moxifloxacin,a or gemifloxacina 3/22/2023 6
  7. Streptococcus, viridans group: • Penicillin G ± gentamicine • Cefotaxime,c ceftriaxone,c erythromycin, azithromycin, clarithromycin, or vancomycin ± gentamicin 3/22/2023 7
  8. Drugs of Choice, First Choice, Alternative(s) 2. GRAM-NEGATIVE COCCI 8 3/22/2023
  9. Moraxella (Branhamella) catarrhalis: • Amoxicillin–clavulanate, ampicillin–sulbactam • Trimethoprim–sulfamethoxazole, erythromycin, azithromycin, clarithromycin, doxycycline,a SGC,c, f cefotaxime,c ceftriaxone,c or TGCPOc,g 3/22/2023 9
  10. Neisseria gonorrhoeae (also give concomitant treatment for Chlamydia trachomatis): • Disseminated gonococcal infection – Ceftriaxonec or cefotaximec – Oral follow-up: cefpodoxime,c ciprofloxacin,a or levofloxacina • Uncomplicated infection – Ceftriaxone,c cefotaxime,c or cefpodoximec – Ciprofloxacina or levofloxacina Neisseria meningitides: • Penicillin G • Cefotaximec or ceftriaxonec 3/22/2023 10
  11. 3. GRAM-POSITIVE BACILLI • Clostridium perfringens – Penicillin G ± clindamycin – Metronidazole,a clindamycin, doxycycline,a cefazolin,c carbapenemh,i • Clostridioides (formerly Clostridium) difficile – oral vancomycin or fidaxomicin – oral metronidazole 3/22/2023 11
  12. Drugs of Choice, First Choice, Alternative(s) 4. GRAM-NEGATIVE BACILLI 12 3/22/2023
  13. Acinetobacter spp.: – Doripenem, imipenem, or meropenem ± aminoglycosidej (amikacin usually most effective) – Ampicillin–sulbactam, polymyxins,i or tigecyclinea • Bacteroides fragilis (and others): – Metronidazolea – BL/BLI,d clindamycin, cefoxitin,c cefotetan,c ceftolozane-azobactam, ceftazidime- avibactam, or carbapenemh,i Enterobacter spp.: – Carbapenemh or cefepime ± aminoglycosidej – Ceftolozane-tazobactam, ceftazidime-avibactam, ciprofloxacin,a levofloxacin,a piperacillin–tazobactam, ticarcillin–clavulanate 3/22/2023 13
  14. Escherichia coli: • Meningitis – Cefotaxime,c ceftriaxone,c meropenem • Systemic infection – Cefotaximec or ceftriaxonec – BL/BLI,d fluoroquinolone,a,k carbapenemh,i • Urinary tract infection – Most oral agents: check sensitivities – Ampicillin, amoxicillin–clavulanate, doxycycline,a or cephalexinc – Aminoglycoside,j FGC,b,c nitrofurantoin, fluoroquinolonea,k 3/22/2023 14
  15. Gardnerella vaginalis: – Metronidazolea – Clindamycin Haemophilus influenza: – Meningitis • Cefotaximec or ceftriaxonec • Meropenemi – Other infections – BL/BLI,d or if β-lactamase-negative, ampicillin or amoxicillin • Trimethoprim–sulfamethoxazole, cefuroxime,c azithromycin, clarithromycin, or fluoroquinolonea,k 3/22/2023 15
  16. Klebsiella pneumonia: – BL/BLI,d cefotaxime,c ceftriaxone,c cefepimec – Carbapenem,h,i ceftolozane-tazobactam, ceftazidime-avibactam, fluoroquinolonea,k Legionella spp.: – Azithromycin, erythromycin ± rifampin, or fluoroquinolonea,k – Trimethoprim–sulfamethoxazole, clarithromycin, or doxycyclinea Pasteurella multocida: – Penicillin G, ampicillin, amoxicillin – Doxycycline,a BL/BLI,d trimethoprim–sulfamethoxazole or ceftriaxonec Proteus mirabilis: – Ampicillin – Trimethoprim–sulfamethoxazole 3/22/2023 16
  17. Proteus (indole-positive) (including Providencia rettgeri, Morganella morganii, and Proteus vulgaris): • Cefotaxime,c ceftriaxone,c or fluoroquinolonea,k • BL/BLI,d aztreonam,l aminoglycosides,j carbapenem,h,i ceftolozanetazobactam, ceftazidime-avibactam Providencia stuartii: • Amikacin, cefotaxime,c ceftriaxone,c fluoroquinolonea,k • Trimethoprim–sulfamethoxazole, aztreonam,l carbapenemh,i 3/22/2023 17
  18. Pseudomonas aeruginosa: • Urinary tract infection only – Aminoglycosidej – Ciprofloxacin,a levofloxacina • Systemic infection – Cefepime,c ceftazidime,c doripenem,i imipenem,i meropenem,I piperacillin– tazobactam, or ticarcillin–clavulanate + aminoglycosidej – Aztreonam,l ceftolozane-tazobactam, ceftazidime-avibactam, ciprofloxacin,a levofloxacin, a polymyxini Salmonella typhi: – Ciprofloxacin,a levofloxacin,c ceftriaxone,c cefotaximec – Trimethoprim–sulfamethoxazole 3/22/2023 18
  19. Serratia marcescens: – Ceftriaxone,c cefotaxime,c cefepime,c ciprofloxacin,a levofloxacina – Aztreonam, l carbapenem, h,i piperacillin–tazobactam, ticarcillin–clavulanate • Stenotrophomonas (Xanthomonas) maltophilia (generally very resistant to all antimicrobials): – Trimethoprim–sulfamethoxazole. – Check sensitivities to ceftazidime,c doxycycline,a minocycline,a and ticarcillin– clavulanate. 3/22/2023 19
  20. 5. MISCELLANEOUS MICROORGANISMS Chlamydia pneumoniae: • Doxycyclinea • Azithromycin, clarithromycin, erythromycin, or fluoroquinolonea,k C. trachomatis: • Azithromycin or doxycyclinea • Levofloxacin,a erythromycin Mycoplasma pneumoniae: • Azithromycin, clarithromycin, erythromycin, fluoroquinolonea,k • Doxycyclinea 3/22/2023 20
  21. 6. SPIROCHETES Treponema pallidum: • Neurosyphilis – Penicillin G – Ceftriaxonec • Primary or secondary – Benzathine, penicillin G – Ceftriaxonec or doxycyclinea Borrelia burgdorferi (choice depends on stage of disease): • Ceftriaxonec or cefuroxime axetil,c doxycycline,a amoxicillin • High-dose penicillin, cefotaximec 3/22/2023 21
Advertisement